We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$659M
AUM Growth
-$194M
Cap. Flow
-$205M
Cap. Flow %
-31.16%
Top 10 Hldgs %
43.01%
Holding
164
New
28
Increased
30
Reduced
27
Closed
56

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$15.1M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
3
FOLD
Amicus Therapeutics
FOLD
+$11.3M
4
NMTR
9 Meters Biopharma
NMTR
+$9.54M
5
MRK icon
Merck
MRK
+$8.77M

Top Sells

Rank Stock Value
1
CEL
Cellcom Israel, Ltd.
CEL
+$14M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.9M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$9.22M
4
RXDX
Ignyta, Inc.
RXDX
+$9.19M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$9.07M

Sector Composition

Rank Sector Weight
1 Healthcare 75.21%
2 Technology 4.55%
3 Financials 1.71%
4 Communication Services 1.32%
5 Consumer Discretionary 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRQR icon
76
ProQR Therapeutics
PRQR
$243M
$2.02M 0.31%
658,500
+128,500
+24% +$413K
KYNB
77
Kyntra Bio
KYNB
$27.2M
$1.84M 0.28%
1,591
-3,200
-67% -$4.21M
MLNT
78
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$1.8M 0.27%
48,779
+8,779
+22% +$577K
PRGO icon
79
Perrigo
PRGO
$1.4B
$1.6M 0.24%
+19,221
New +$1.68M
RDCM icon
80
Radcom
RDCM
$171M
$1.21M 0.18%
65,760
– –
VTGN icon
81
VistaGen Therapeutics
VTGN
$9.89M
$1.16M 0.18%
41,575
– –
VTVT icon
82
vTv Therapeutics
VTVT
$127M
$1.15M 0.17%
7,042
– –
NGNE icon
83
Neurogene
NGNE
$656M
$1.06M 0.16%
3,777
– –
CHTR icon
84
Charter Communications
CHTR
$17.3B
$1.04M 0.16%
3,329
-8,300
-71% -$2.92M
GILT icon
85
Gilat Satellite Networks
GILT
$834M
$985K 0.15%
+111,646
New +$938K
META icon
86
Meta Platforms (Facebook)
META
$1.42T
$974K 0.15%
6,097
-27,970
-82% -$5.02M
SEDG icon
87
SolarEdge
SEDG
$2.51B
$904K 0.14%
+17,190
New +$754K
EVOK
88
DELISTED
Evoke Pharma
EVOK
$819K 0.12%
2,735
-2,606
-49% -$857K
DCPH
89
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$819K 0.12%
40,846
-183,308
-82% -$4.64M
AAP icon
90
Advance Auto Parts
AAP
$3.35B
$633K 0.1%
5,336
-3,000
-36% -$343K
TMX
91
DELISTED
Terminix Global Holdings, Inc.
TMX
$483K 0.07%
14,184
+2,240
+19% +$78K
UNH icon
92
UnitedHealth
UNH
$376B
$428K 0.07%
2,000
– –
RDWR icon
93
Radware
RDWR
$1.1B
$389K 0.06%
+18,230
New +$378K
WSO icon
94
Watsco Inc
WSO
$12.7B
$380K 0.06%
2,100
– –
CMCSA icon
95
Comcast
CMCSA
$85B
$342K 0.05%
10,000
-36,905
-79% -$1.43M
MHK icon
96
Mohawk Industries
MHK
$7.5B
$255K 0.04%
1,100
– –
CSTE icon
97
Caesarstone
CSTE
$72.3M
$240K 0.04%
+12,195
New +$263K
SITE icon
98
SiteOne Landscape Supply
SITE
$4.12B
$231K 0.04%
+3,000
New +$221K
SNA icon
99
Snap-on
SNA
$21.2B
$202K 0.03%
1,366
-5,926
-81% -$974K
ULTI
100
DELISTED
Ultimate Software Group Inc
ULTI
$195K 0.03%
800
– –
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2018 Portfolio in Review

As of Q1 2018, Sphera Funds Management held 164 positions worth $659M, down 23% from $852M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Sphera Funds Management withdrew a net $205M in Q1 2018, closing 56 positions and reducing 27 holdings. Its most notable exit was Cellcom Israel, Ltd., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 59% a quarter earlier, followed by Technology and Financials.

Against the trend, Sphera Funds Management opened a new position in Regeneron Pharmaceuticals worth $14.3M.

  • Sphera Funds Management's largest Q1 2018 buy was Regeneron Pharmaceuticals: 41,500 shares worth $14.3M.
  • Sphera Funds Management added most to Shire pic in Q1 2018, an estimated $15.1M increase.
  • Sphera Funds Management's biggest Q1 2018 reduction was Sarepta Therapeutics, cutting an estimated $9.07M.
  • Sphera Funds Management fully exited Cellcom Israel, Ltd. in Q1 2018, selling an estimated $14M.
  • Sphera Funds Management's ten largest holdings make up 43% of its $659M portfolio in Q1 2018.
  • Sphera Funds Management opened 28 new positions and closed 56 in Q1 2018.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $659M.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.